So Kanji, Tamura Gen, Honda Teiichiro, Homma Naoyuki, Waki Takayoshi, Togawa Naoyuki, Nishizuka Satoshi, Motoyama Teiichi
Department of Pathology, Yamagata University School of Medicine, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan.
Cancer Sci. 2006 Nov;97(11):1155-8. doi: 10.1111/j.1349-7006.2006.00302.x. Epub 2006 Sep 5.
A number of tumor suppressor and tumor-related genes are silenced by promoter hypermethylation in gastric cancer. Hypermethylation is not restricted to cancer cells, but is also present in non-neoplastic cells during aging. Such age-related methylation in non-neoplastic gastric epithelia is postulated to constitute a field defect that increases the risk for development of gastric cancer. To quantitatively evaluate age-related methylation in non-neoplastic gastric epithelia, we used a fiber-type DNA microarray on which methylated and unmethylated sequence probes were mounted. After bisulfite modification, a part of the promoter CpG island of four tumor suppressor genes, lysyl oxidase (LOX), p16, RUNX3 and tazarotene-induced gene 1 (TIG1), were amplified by PCR using Cy5 end labeled primers. Methylation rates (MRs) were calculated as the ratio of the fluorescence intensity of a methylated sequence probe to the total fluorescence intensity of methylated and unmethylated probes. Non-neoplastic gastric mucosa was obtained from 24 non-cancer-bearing stomachs at autopsy. MRs ranged from 0.0% to 77.2% (mean, 15.8%) for LOX, 0.0% to 45.8% (mean, 10.0%) for p16, 0.0% to 83.8% (mean, 9.0%) for RUNX3, and 0.0% to 46.1% (mean, 6.6%) for TIG1, and significantly correlated with aging (P < 0.01). The regression curves were: y = 0.013x(2) - 0.6184x + 4.0512, R(2) = 0.5728 (P < 0.001) for LOX; y = 0.0107x(2) - 0.6055x + 5.2943, R(2) = 0.7891 (P < 0.00001) for p16; y = 0.0182x(2) - 1.2234x + 11.566, R(2) = 0.5595 (P < 0.001) for RUNX3; and y = 0.0068 x(2) - 0.3586 x + 2.4306, R(2) = 0.4670 (P < 0.01) for TIG1. Thus, our present results are consistent with the notion that age-related methylation is associated with cancer susceptibility in the elderly. Quantitative analysis of DNA methylation using DNA microarrays is a promising method for risk assessment in the development of gastric cancer.
在胃癌中,许多肿瘤抑制基因和肿瘤相关基因通过启动子高甲基化而沉默。高甲基化并不局限于癌细胞,在衰老过程中的非肿瘤细胞中也存在。非肿瘤性胃上皮中这种与年龄相关的甲基化被认为构成了一种场缺陷,增加了胃癌发生的风险。为了定量评估非肿瘤性胃上皮中与年龄相关的甲基化,我们使用了一种纤维型DNA微阵列,其上安装了甲基化和未甲基化的序列探针。经过亚硫酸氢盐修饰后,使用Cy5末端标记引物通过PCR扩增四个肿瘤抑制基因(赖氨酰氧化酶(LOX)、p16、RUNX3和他扎罗汀诱导基因1(TIG1))启动子CpG岛的一部分。甲基化率(MRs)计算为甲基化序列探针的荧光强度与甲基化和未甲基化探针总荧光强度的比值。从24例尸检时的非癌性胃中获取非肿瘤性胃黏膜。LOX的MRs范围为0.0%至77.2%(平均15.8%),p16为0.0%至45.8%(平均10.0%),RUNX3为0.0%至83.8%(平均9.0%),TIG1为0.0%至46.1%(平均6.6%),且与衰老显著相关(P < 0.01)。回归曲线分别为:LOX:y = 0.013x(2) - 0.6184x + 4.0512,R(2) = 0.5728(P < 0.001);p16:y = 0.0107x(2) - 0.6055x + 5.2943,R(2) = 0.7891(P < 0.00001);RUNX3:y = 0.0182x(2) - 1.2234x + 11.566,R(2) = 0.5595(P < 0.001);TIG1:y = 0.0068 x(2) - 0.3586 x + 2.4306,R(2) = 0.4670(P < 0.01)。因此,我们目前的结果与以下观点一致,即与年龄相关的甲基化与老年人的癌症易感性相关。使用DNA微阵列对DNA甲基化进行定量分析是一种用于评估胃癌发生风险的有前景的方法。